Your browser doesn't support javascript.
loading
INPP4B is an oncogenic regulator in human colon cancer.
Guo, S T; Chi, M N; Yang, R H; Guo, X Y; Zan, L K; Wang, C Y; Xi, Y F; Jin, L; Croft, A; Tseng, H-Y; Yan, X G; Farrelly, M; Wang, F H; Lai, F; Wang, J F; Li, Y P; Ackland, S; Scott, R; Agoulnik, I U; Hondermarck, H; Thorne, R F; Liu, T; Zhang, X D; Jiang, C C.
Affiliation
  • Guo ST; Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Shanxi, China.
  • Chi MN; School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
  • Yang RH; Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Shanxi, China.
  • Guo XY; Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Shanxi, China.
  • Zan LK; Department of Pathology, Shanxi Cancer Hospital and Institute, Shanxi, China.
  • Wang CY; Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Shanxi, China.
  • Xi YF; Department of Pathology, Shanxi Cancer Hospital and Institute, Shanxi, China.
  • Jin L; School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
  • Croft A; Department of Medical Oncology, Calvary Mater Newcastle Hospital, Newcastle, New South Wales, Australia.
  • Tseng HY; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia.
  • Yan XG; School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
  • Farrelly M; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia.
  • Wang FH; Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Shanxi, China.
  • Lai F; School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
  • Wang JF; Department of Pathology, Shanxi Cancer Hospital and Institute, Shanxi, China.
  • Li YP; Department of Colorectal Surgery, Shanxi Cancer Hospital and Institute, Shanxi, China.
  • Ackland S; Department of Medical Oncology, Calvary Mater Newcastle Hospital, Newcastle, New South Wales, Australia.
  • Scott R; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia.
  • Agoulnik IU; Department of Cellular Biology and Pharmacology, Herbert Wertheim College of Medicine, Miami, FL, USA.
  • Hondermarck H; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia.
  • Thorne RF; School of Environmental and Life Sciences, University of Newcastle, Callaghan, New South Wales, Australia.
  • Liu T; Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, New South Wales, Australia.
  • Zhang XD; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia.
  • Jiang CC; School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
Oncogene ; 35(23): 3049-61, 2016 06 09.
Article in En | MEDLINE | ID: mdl-26411369

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms / Phosphoric Monoester Hydrolases Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2016 Document type: Article Affiliation country: China Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms / Phosphoric Monoester Hydrolases Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2016 Document type: Article Affiliation country: China Country of publication: United kingdom